Cambridge Raman Imaging

Cambridge Raman Imaging Limited (CRI) is a UK-based company founded in March 2018, specializing in advanced biomedical imaging technologies. As a spin-out from the University of Cambridge and the Politecnico di Milano, CRI focuses on developing ultra-fast fiber laser systems for coherent Raman spectroscopy, primarily for clinical diagnosis and biotech research. The company's flagship product, the STRALE laser system, enables high-speed, high-resolution, label-free, and non-invasive Raman imaging. This technology allows for rapid chemical and morphological analysis of tissues and cells, significantly enhancing the accuracy and timeliness of disease diagnoses, especially in histopathology. The STRALE systems are designed for integration with standard medical microscopes, making them suitable for use in pathology laboratories and operating theatres, facilitating real-time analysis of fresh tissue samples during surgery. CRI is expanding its global presence with a subsidiary in Italy and has received various funding, including EU grants. The company is recognized as an innovator in AI-integrated chemometric platforms, aiming to enhance diagnostic clarity and support future applications in endoscopic examinations and protein imaging.

• Employees 11
• Founded 2018
• Annual Revenue $1000000
• Total Funding $1696118